2 S&P 500 Stocks to Own for Decades and 1 We Question
3 Mid-Cap Stocks We Steer Clear Of
3 Healthcare Stocks with Questionable Fundamentals
The healthcare sector has had a mixed year, yet Solventum shareholders might feel as though they drew the short straw.
Cooper Companies has lagged behind the healthcare sector over the past year, and analysts remain moderately bullish about its prospects.
1 Profitable Stock with Exciting Potential and 2 That Underwhelm
EAGAN, Minn. , May 27, 2026 /PRNewswire/ -- Solventum (NYSE: SOLV) announced today that management will participate in a fireside chat at the Jefferies Healthcare Conference on Wednesday, Jun....
1 Unpopular Stock That Should Get More Attention and 2 We Turn Down
While Solventum has considerably underperformed the broader market over the past 52 weeks, Wall Street analysts maintain a moderately optimistic outlook about the stock’s prospects.
Spin-offs and mergers can lead to major movement for share prices, but accessing these scenarios can be challenging for investors; these ETFs can help.